Thymoquinone reversed doxorubicin resistance in U87 glioblastoma cells via targeting PI3K /Akt/ mTOR signaling
Year: 2024
Type: article
Source: Chemical Biology & Drug Design
DOI: 10.1111/cbdd.14587
Institution: Tabriz University of Medical Sciences
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4401830228